Winthrop Advisory Group
VRTX icon

Winthrop Advisory Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Winthrop Advisory Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$308K Sell
589
-5
-0.8% -$2.56K 0.02% 166
2026
Q2 		$295K Buy
594
+105
+21% +$46.5K 0.02% 175
2026
Q1 		$218K Buy
+489
New +$228K 0.02% 178

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
AMF Tjänstepension
AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Montrusco Bolton Investments
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

Winthrop Advisory Group's VRTX Position: Q3 2026 in Review

Winthrop Advisory Group reduced its Vertex Pharmaceuticals (VRTX) stake by 0.84% in Q3 2026, selling an estimated $2.56K and leaving 589 shares worth $308K. The position accounts for 0.02% of the portfolio, ranked #166.

Winthrop Advisory Group first reported a position in VRTX in Q1 2026 and has held it in 3 quarters since. 458 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Winthrop Advisory Group held 589 shares of Vertex Pharmaceuticals worth $308K as of Q3 2026.
  • Winthrop Advisory Group sold 5 Vertex Pharmaceuticals shares in Q3 2026, an estimated $2.56K.
  • Vertex Pharmaceuticals made up 0.02% of Winthrop Advisory Group's portfolio in Q3 2026, its #166 holding.
  • Winthrop Advisory Group first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 458 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Winthrop Advisory Group's 13F filing for Q3 2026, filed 22 Oct 2026.